Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Men aged 18 or older who have been referred by a doctor due to a suspicion of prostate cancer and are being considered for a prostate biopsy
- People who are able to complete all of the procedures required by the trial
- People who are able to give written consent to participate
Who may not be able to join:
- People who have already been diagnosed with prostate cancer
- People for whom an MRI scan would not be safe or suitable, such as those with claustrophobia, a pacemaker, or reduced kidney function (confirm with trial site)
- People for whom a prostate biopsy would not be safe or suitable (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Arturo Chiti, MD, IRCCS Ospedale San Raffaele
Phone: 02-26436117
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
To assess the accuracy and the predictive value of fully hybrid 18F-PSMA PET/MRI for the diagnosis of clinically significant prostate cancer (csPCa)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.